Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AMLX |
---|---|---|
09:32 ET | 11689 | 3.015 |
09:34 ET | 4682 | 3.01 |
09:36 ET | 5070 | 2.98 |
09:38 ET | 100 | 2.985 |
09:39 ET | 2513 | 2.99 |
09:41 ET | 1100 | 2.99 |
09:43 ET | 700 | 2.995 |
09:45 ET | 6343 | 3.03 |
09:48 ET | 55388 | 3.0401 |
09:50 ET | 7229 | 3.06 |
09:52 ET | 1150 | 3.055 |
09:54 ET | 7482 | 3.0301 |
09:56 ET | 500 | 3.035 |
09:57 ET | 5378 | 3.035 |
09:59 ET | 1080 | 3.02 |
10:01 ET | 731 | 3.005 |
10:03 ET | 959 | 3.02 |
10:06 ET | 8346 | 3.005 |
10:08 ET | 100 | 3.005 |
10:10 ET | 3457 | 3.01 |
10:12 ET | 200 | 3.015 |
10:14 ET | 460 | 3.015 |
10:15 ET | 378 | 3.02 |
10:17 ET | 744 | 3.015 |
10:19 ET | 3990 | 3.035 |
10:21 ET | 3198 | 3.035 |
10:24 ET | 1952 | 3.03 |
10:26 ET | 3627 | 3.029304 |
10:28 ET | 3605 | 3.03 |
10:30 ET | 2528 | 3.0166 |
10:32 ET | 100 | 3.02 |
10:33 ET | 100 | 3.02 |
10:35 ET | 4412 | 3.0101 |
10:37 ET | 203 | 3.015 |
10:39 ET | 100 | 3.015 |
10:42 ET | 1900 | 3.015 |
10:44 ET | 826 | 3.015 |
10:46 ET | 6450 | 3.015 |
10:48 ET | 400 | 3.02 |
10:50 ET | 100 | 3.015 |
10:51 ET | 2997 | 3.025 |
10:53 ET | 1610 | 3.025 |
10:55 ET | 2289 | 3.02 |
10:57 ET | 400 | 3.0112 |
11:00 ET | 400 | 3.015 |
11:02 ET | 715 | 3.02 |
11:04 ET | 3148 | 3.025 |
11:06 ET | 25624 | 3.015 |
11:09 ET | 331 | 3.02 |
11:11 ET | 3925 | 3.025 |
11:13 ET | 5900 | 3.045 |
11:15 ET | 1300 | 3.04 |
11:18 ET | 2152 | 3.0391 |
11:20 ET | 712 | 3.035 |
11:22 ET | 200 | 3.035 |
11:24 ET | 6384 | 3.025 |
11:26 ET | 100 | 3.025 |
11:27 ET | 2300 | 3.02 |
11:29 ET | 7121 | 3.035 |
11:31 ET | 2726 | 3.025 |
11:33 ET | 200 | 3.03 |
11:36 ET | 3648 | 3.04 |
11:40 ET | 3715 | 3.05 |
11:42 ET | 2923 | 3.06 |
11:44 ET | 4512 | 3.0687 |
11:45 ET | 2000 | 3.0632 |
11:49 ET | 5638 | 3.08 |
11:51 ET | 1886 | 3.075 |
11:54 ET | 4719 | 3.085 |
11:56 ET | 2195 | 3.08 |
11:58 ET | 800 | 3.09 |
12:00 ET | 603 | 3.085 |
12:02 ET | 2966 | 3.0889 |
12:03 ET | 7508 | 3.085 |
12:05 ET | 100 | 3.085 |
12:07 ET | 500 | 3.085 |
12:09 ET | 300 | 3.08 |
12:14 ET | 2200 | 3.09 |
12:16 ET | 4650 | 3.09 |
12:18 ET | 4016 | 3.085 |
12:20 ET | 1819 | 3.085 |
12:21 ET | 2173 | 3.085 |
12:23 ET | 500 | 3.085 |
12:25 ET | 11731 | 3.095 |
12:27 ET | 300 | 3.095 |
12:30 ET | 333 | 3.095 |
12:32 ET | 2612 | 3.105 |
12:34 ET | 1100 | 3.1 |
12:36 ET | 1600 | 3.105 |
12:38 ET | 1060 | 3.105 |
12:39 ET | 5363 | 3.125 |
12:41 ET | 7411 | 3.125 |
12:43 ET | 288 | 3.125 |
12:45 ET | 10355 | 3.15 |
12:48 ET | 23824 | 3.13 |
12:50 ET | 13170 | 3.13 |
12:52 ET | 6501 | 3.115 |
12:54 ET | 2500 | 3.11 |
12:56 ET | 400 | 3.12 |
12:57 ET | 443 | 3.115 |
12:59 ET | 4291 | 3.11 |
01:01 ET | 2528 | 3.1059 |
01:03 ET | 100 | 3.105 |
01:06 ET | 2062 | 3.105 |
01:08 ET | 100 | 3.11 |
01:10 ET | 1977 | 3.115 |
01:12 ET | 1168 | 3.12 |
01:14 ET | 437 | 3.115 |
01:15 ET | 641 | 3.115 |
01:17 ET | 200 | 3.115 |
01:19 ET | 1200 | 3.115 |
01:21 ET | 4969 | 3.12 |
01:24 ET | 2942 | 3.115 |
01:28 ET | 3944 | 3.11 |
01:30 ET | 438 | 3.101313 |
01:32 ET | 600 | 3.105 |
01:33 ET | 100 | 3.1 |
01:35 ET | 1004 | 3.1 |
01:37 ET | 300 | 3.1 |
01:39 ET | 3208 | 3.105 |
01:42 ET | 100 | 3.105 |
01:44 ET | 100 | 3.105 |
01:46 ET | 2720 | 3.115 |
01:48 ET | 2612 | 3.115 |
01:50 ET | 578 | 3.115 |
01:51 ET | 471 | 3.11 |
01:53 ET | 4834 | 3.11 |
01:55 ET | 807 | 3.11 |
01:57 ET | 400 | 3.11 |
02:00 ET | 300 | 3.11 |
02:02 ET | 600 | 3.11 |
02:04 ET | 1159 | 3.105 |
02:06 ET | 200 | 3.1013 |
02:08 ET | 700 | 3.105 |
02:09 ET | 434 | 3.11 |
02:11 ET | 100 | 3.105 |
02:13 ET | 100 | 3.105 |
02:15 ET | 200 | 3.105 |
02:20 ET | 100 | 3.11 |
02:22 ET | 2642 | 3.115 |
02:24 ET | 1043 | 3.115 |
02:26 ET | 1260 | 3.11 |
02:27 ET | 700 | 3.11 |
02:29 ET | 1000 | 3.11 |
02:31 ET | 300 | 3.11 |
02:33 ET | 5454 | 3.11 |
02:36 ET | 200 | 3.105 |
02:38 ET | 2743 | 3.1119 |
02:40 ET | 370 | 3.115 |
02:42 ET | 200 | 3.12 |
02:44 ET | 1910 | 3.115 |
02:45 ET | 100 | 3.12 |
02:47 ET | 200 | 3.12 |
02:49 ET | 3079 | 3.125 |
02:51 ET | 110 | 3.125 |
02:54 ET | 300 | 3.1214 |
02:58 ET | 300 | 3.125 |
03:00 ET | 603 | 3.1254 |
03:02 ET | 404 | 3.1296 |
03:03 ET | 4261 | 3.125 |
03:05 ET | 2131 | 3.135 |
03:07 ET | 340 | 3.135 |
03:14 ET | 2724 | 3.14 |
03:16 ET | 800 | 3.14 |
03:18 ET | 1700 | 3.145 |
03:20 ET | 4134 | 3.14 |
03:21 ET | 130 | 3.135 |
03:23 ET | 1580 | 3.135 |
03:25 ET | 1263 | 3.135 |
03:27 ET | 400 | 3.135 |
03:32 ET | 100 | 3.135 |
03:34 ET | 10550 | 3.125 |
03:36 ET | 992 | 3.125 |
03:38 ET | 11356 | 3.115 |
03:39 ET | 1976 | 3.11 |
03:41 ET | 1080 | 3.115 |
03:45 ET | 2150 | 3.11 |
03:48 ET | 11673 | 3.125 |
03:50 ET | 5200 | 3.1202 |
03:52 ET | 5063 | 3.115 |
03:54 ET | 700 | 3.12 |
03:56 ET | 2950 | 3.115 |
03:57 ET | 15440 | 3.105 |
03:59 ET | 109048 | 3.14 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Amylyx Pharmaceuticals Inc | 212.4M | -1.3x | --- |
Amarin Corporation PLC | 248.9M | -7.3x | --- |
Organogenesis Holdings Inc | 408.3M | -24.6x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Ironwood Pharmaceuticals Inc | 686.9M | 99.5x | --- |
Coherus BioSciences Inc | 119.8M | -2.6x | --- |
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $212.4M |
---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.